Literature DB >> 16447113

Injection drug users: the overlooked core of the hepatitis C epidemic.

Brian R Edlin, Michael R Carden.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16447113      PMCID： PMC1611492          DOI： 10.1086/499960

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  45 in total

1.  Liver transplantation and opioid dependence.

Authors:  M Koch; P Banys
Journal:  JAMA       Date:  2001-02-28       Impact factor: 56.272

2.  Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif.

Authors:  J Lorvick; A H Kral; K Seal; L Gee; B R Edlin
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

3.  Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Authors:  B R Edlin; K H Seal; J Lorvick; A H Kral; D H Ciccarone; L D Moore; B Lo
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

4.  The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.

Authors:  G L Armstrong; M J Alter; G M McQuillan; H S Margolis
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

5.  Treatment of hepatitis C infection in injection drug users.

Authors:  M Backmund; K Meyer; M Von Zielonka; D Eichenlaub
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

6.  Managing chronic hepatitis C acquired through intravenous drug use.

Authors:  S L Jowett; K Agarwal; B C Smith; W Craig; M Hewett; D R Bassendine; E Gilvarry; A D Burt; M F Bassendine
Journal:  QJM       Date:  2001-03

7.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

8.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

Review 9.  Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study.

Authors:  Shirley A Coverdale; Mahbub H Khan; Karen Byth; Rita Lin; Martin Weltman; Jacob George; Dev Samarasinghe; Christopher Liddle; James G Kench; Evelyn Crewe; Geoffrey C Farrell
Journal:  Am J Gastroenterol       Date:  2004-04       Impact factor: 10.864

10.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307
View more
  33 in total

1.  Low rates of hepatitis A and B vaccination in patients with chronic hepatitis C at an urban methadone maintenance program.

Authors:  Uriel R Felsen; Dawn A Fishbein; Alain H Litwin
Journal:  J Addict Dis       Date:  2010-10

2.  The beginning of a new era in understanding hepatitis C virus prevention.

Authors:  Josiah D Rich; Lynn E Taylor
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

3.  Risk Behaviors Among Suburban Women who Use Methamphetamine: Social Harms and Social Solutions.

Authors:  Aukje Lamonica; Miriam Boeri
Journal:  J Appl Soc Sci (Boulder)       Date:  2015-09-01

Review 4.  Treatment of acute HCV infection.

Authors:  Jason Grebely; Gail V Matthews; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-03-22       Impact factor: 46.802

5.  Managing chronic hepatitis C in primary-care settings: more than antiviral therapy.

Authors:  Barry Zevin
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

6.  Inactivation and survival of hepatitis C virus on inanimate surfaces.

Authors:  Juliane Doerrbecker; Martina Friesland; Sandra Ciesek; Thomas J Erichsen; Pedro Mateu-Gelabert; Jörg Steinmann; Jochen Steinmann; Thomas Pietschmann; Eike Steinmann
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

7.  Health disparities and the criminal justice system: an agenda for further research and action.

Authors:  Ingrid A Binswanger; Nicole Redmond; John F Steiner; Leroi S Hicks
Journal:  J Urban Health       Date:  2012-02       Impact factor: 3.671

8.  Silence Surrounding Hepatitis C Status in Risk Relationships Among Rural People Who Use Drugs.

Authors:  Megan G Hofmeister; Jennifer R Havens; April M Young
Journal:  J Prim Prev       Date:  2017-10

9.  Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users.

Authors:  William A Zule; Elizabeth C Costenbader; Curtis M Coomes; Wendee M Wechsberg
Journal:  Am J Public Health       Date:  2009-02-12       Impact factor: 9.308

10.  Injection drug use is a risk factor for HCV infection in urban Egypt.

Authors:  Adela Paez Jimenez; Mostafa K Mohamed; Noha Sharaf Eldin; Hasnaa Abou Seif; Said El Aidi; Yehia Sultan; Nasr Elsaid; Claire Rekacewicz; Mostafa El-Hoseiny; May El-Daly; Mohamed Abdel-Hamid; Arnaud Fontanet
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.